Optimizing vaccination with mRNA-transfected Dendritic Cells by evaluating concepts in vitro (C01) (SFB 643)

Third Party Funds Group - Sub project


Acronym: SFB 643

Start date : 01.07.2004

End date : 31.12.2012

Universitätsklinikum Erlangen (UK) DE Germany (DE)